Generics 8

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Fondaparinux manufacturers

8 products found

Filters

8 products found

fondaparinux

Injection, pre-filled syringe 1.5 mg/0.3 ml, 2.5 mg/0.5 ml, 5 mg/7.5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #554
This company focuses on developing and manufacturing a range of pharmaceuticals and healthcare products. Their offerings include prescription medications, over-the-counter drugs, and potentially medical devices or supplements, though specifics are not provided. They appear to have a strong research and development focus, with expertise in several key therapy areas (not specified). The company operates within regions like the EU and North America, adhering to stringent GMP certifications for production. While patent information is unavailable, their commitment to innovation is evident through their product development pipeline.

Manufacturer usually replies in 6 days

fondaparinux

Solution for injection 2.5 mg/0.5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP
Unavailable markets
Iraq , Kazakhstan , Ukraine , Uzbekistan , Vietnam
Comments
RX
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 27 days

fondaparinux

Injection 2.5 mg/0.5 ml, 5 mg/0.4 ml, 7.5 mg/0.6 ml, 10 mg/0.8 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #38346
Manufacturer was incorporated on 27 December 2021 in Surat, Gujarat, India, with about 28 employees. As a CTD dossier owner and manufacturer, it operates a WHO-GMP certified and EU-compliant formulation plant under CGMP norms. Products reach markets in India, Yemen, Zambia, Venezuela, Ghana, Kenya, and Tanzania for international presence. Designed to comply with rigorous “Revised Schedule M” rules from India’s Drug Controller. As a CTD dossier owner and manufacturer, it aims for regulatory readiness in global submissions. Recognized as a GMP manufacturer, it ensures standards of safety, purity, and efficacy in all batches.

Want to see all 8 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible